1. Home
  2. AVA vs IDYA Comparison

AVA vs IDYA Comparison

Compare AVA & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avista Corporation

AVA

Avista Corporation

HOLD

Current Price

$38.77

Market Cap

3.1B

Sector

Utilities

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$34.11

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVA
IDYA
Founded
1889
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
AVA
IDYA
Price
$38.77
$34.11
Analyst Decision
Hold
Strong Buy
Analyst Count
2
14
Target Price
$39.50
$49.42
AVG Volume (30 Days)
726.0K
926.1K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
5.08%
N/A
EPS Growth
N/A
N/A
EPS
2.35
N/A
Revenue
$1,964,000,000.00
$214,834,000.00
Revenue This Year
$1.75
$2,434.86
Revenue Next Year
N/A
N/A
P/E Ratio
$16.41
N/A
Revenue Growth
2.14
5377.66
52 Week Low
$34.80
$13.45
52 Week High
$43.09
$37.08

Technical Indicators

Market Signals
Indicator
AVA
IDYA
Relative Strength Index (RSI) 41.30 53.00
Support Level $38.19 $33.12
Resistance Level $39.32 $37.08
Average True Range (ATR) 0.64 1.45
MACD -0.24 -0.33
Stochastic Oscillator 16.72 19.41

Price Performance

Historical Comparison
AVA
IDYA

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: